CHICAGO & BOSTON--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions and On Belay Health Solutions, the company on a mission to empower ...
NLP-enhanced data from over 154 million patient records facilitates innovation in real-world evidence research via the Veradigm Network CHICAGO--(BUSINESS WIRE)-- Veradigm® (OTCMKTS: MDRX), a leading ...
Veradigm(R) (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of ...
Veradigm(R) (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced the integration of two new datasets to expand the depth and breadth of Veradigm Network EHR ...
Two solutions will initiate this extended collaboration focused on the linking of real-world data to both clinical trial data and specific therapeutic area data. CHICAGO--(BUSINESS WIRE)--Veradigm®, ...
CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a leader in providing ...
CHICAGO, September 30, 2025--(BUSINESS WIRE)--Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing estimated financial performance for the second ...
Veradigm Inc (NASDAQ:MDRX) shares are trading lower after it provided below-consensus FY23 guidance. For FY23, the company expects revenue (on a GAAP basis) of $608 million-$622 million (vs. $637.67 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback